Breaking 340B: What Happens After Medicare Payment Cut?

CMS’ reduced payment for drugs purchased at 340B prices went into effect January 1 – but still faces potential legal and legislative challenges. But the real question is what will happen if it sticks?

Silhouette of a doctor walking in a hurry in the hospital corridor.

As of Jan. 1, Medicare is paying hospital outpatient providers a dramatically lower amount for prescription drugs purchased at the 340B discount price: Average Sales Price minus 22.5% rather than the standard ASP+6%.

The Centers for Medicare & Medicaid Services made the change as part of the Hospital Outpatient Prospective Payment System rule...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access